文献速递复苏、休克与脓毒症呼吸衰竭与机械通气重症综合管理与镇静镇痛

探索脓毒症患者脉搏血氧饱和度的最佳范围:基于MIMIC-IV数据的回顾性研究

[Exploring the optimal range of pulse oxygen saturation in patients with sepsis: a retrospective study based on MIMIC- IV data].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2024-01-01
一句话结论脓毒症患者住院期间SpO2与院内全因死亡率呈U型关系,SpO2在0.96-0.98之间死亡率最低。

该研究基于MIMIC-IV数据库,纳入5 937例脓毒症患者,其中1 191例(20.1%)院内死亡。采用广义相加模型结合Loess平滑函数分析住院期间SpO2与院内全因死亡率的非线性关系,发现两者呈U型关系。多因素Logistic回归证实SpO2在0.96-0.98之间的患者死亡率低于SpO2<0.96组(OR=2.659,95%CI 2.190-3.229,P<0.001)和SpO2>0.98组(OR=1.594,95%CI 1.337-1.900,P<0.001)。Kaplan-Meier生存曲线显示SpO2 0.96-0.98组生存概率更高(Log-Rank χ²=113.400,P<0.001)。

要点

  • 脓毒症患者住院期间SpO2与院内全因死亡率呈U型关系,过高和过低氧水平均与死亡风险增加相关。
  • SpO2 0.96-0.98组死亡率低于SpO2<0.96组(OR=2.659,95%CI 2.190-3.229,P<0.001)。
  • SpO2 0.96-0.98组死亡率低于SpO2>0.98组(OR=1.594,95%CI 1.337-1.900,P<0.001)。
  • Kaplan-Meier曲线显示SpO2 0.96-0.98组生存概率高于SpO2<0.96组和SpO2>0.98组(Log-Rank χ²=113.400,P<0.001)。
  • 敏感性分析中,除样本量较小的亚组外,按年龄、性别、BMI、入院类型、种族、心率、收缩压、舒张压、平均动脉压、呼吸频率、体温、心肌梗死、充血性心力衰竭、脑血管病、慢性肝病、糖尿病、SOFA、SAPS II、SIRS、GCS分层,SpO2 0.96-0.98组死亡率均显著低于SpO2<0.96组和SpO2>0.98组。

适用人群与场景

  • 脓毒症患者,数据来自MIMIC-IV数据库,纳入5 937例符合纳入标准者。

研究设计与关键结果

  • 研究类型:病例对照研究设计,基于MIMIC-IV数据提取脓毒症患者人口学信息、生命体征、合并症、实验室参数、危重病评分、临床治疗信息和临床结局。
  • 样本量:5 937例符合纳入标准,其中1 191例(20.1%)院内死亡。
  • 主要终点:广义相加模型结合Loess平滑函数分析显示住院期间SpO2与院内全因死亡率呈非线性U型关系。
  • 多因素Logistic回归:SpO2 0.96-0.98组死亡率低于SpO2<0.96组(缺氧组;OR=2.659,95%CI 2.190-3.229,P<0.001)和SpO2>0.98组(高氧组;OR=1.594,95%CI 1.337-1.900,P<0.001)。
  • Kaplan-Meier生存曲线:SpO2 0.96-0.98组生存概率高于SpO2<0.96组和SpO2>0.98组(Log-Rank检验:χ²=113.400,P<0.001)。
  • 敏感性分析:除样本量较小的亚组外,按年龄、性别、BMI、入院类型、种族、心率、收缩压、舒张压、平均动脉压、呼吸频率、体温、心肌梗死、充血性心力衰竭、脑血管病、慢性肝病、糖尿病、SOFA、SAPS II、SIRS、GCS分层,SpO2 0.96-0.98组死亡率均显著低于SpO2<0.96组和SpO2>0.98组。

证据类型、等级与局限

  • 证据类型:基于MIMIC-IV数据库的病例对照研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为脓毒症患者住院期间SpO2与院内全因死亡率呈U型关系,过高和过低氧水平均与死亡风险增加相关,最佳SpO2范围为0.96-0.98。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To explore the optimal pulse oxygen saturation (SpO2) range during hospitalization for patients with sepsis.

METHODS: A case-control study design was employed. Demographic information, vital signs, comorbidities, laboratory parameters, critical illness scores, clinical treatment information, and clinical outcomes of sepsis patients were extracted from the Medical Information Mart for Intensive Care- IV (MIMIC- IV). A generalized additive model (GAM) combined with a Loess smoothing function was employed to analyze and visualize the nonlinear relationship between SpO2 levels during hospitalization and in-hospital all-cause mortality. The optimal range of SpO2 was determined, and Logistic regression model along with Kaplan-Meier curve were utilized to validate the association between the determined range of SpO2 and in-hospital all-cause mortality.

RESULTS: A total of 5 937 patients met the inclusion criteria, among whom 1 191 (20.1%) died during hospitalization. GAM analysis revealed a nonlinear and U-shaped relationship between SpO2 levels and in-hospital all-cause mortality among sepsis patients during hospitalization. Multivariable Logistic regression analysis further confirmed that patients with SpO2 levels between 0.96 and 0.98 during hospitalization had a decreased mortality compared to those with SpO2 < 0.96 [hypoxia group; odds ratio (OR) = 2.659, 95% confidence interval (95%CI) was 2.190-3.229, P < 0.001] and SpO2 > 0.98 (hyperoxia group; OR = 1.594, 95%CI was 1.337-1.900, P < 0.001). Kaplan-Meier survival curve showed that patients with SpO2 between 0.96 and 0.98 during hospitalization had a higher probability of survival than those patient with SpO2 < 0.96 and SpO2 > 0.98 (Log-Rank test: χ 2 = 113.400, P < 0.001). Sensitivity analyses demonstrated that, with the exception of subgroups with smaller sample sizes, across the strata of age, gender, body mass index (BMI), admission type, race, heart rate, systolic blood pressure, diastolic blood pressure, mean arterial pressure, respiratory rate, body temperature, myocardial infarction, congestive heart failure, cerebrovascular disease, chronic liver disease, diabetes mellitus, sequential organ failure assessment (SOFA), simplified acute physiology score II (SAPS II), systemic inflammatory response syndrome score (SIRS), and Glasgow coma score (GCS), the mortality of patients with SpO2 between 0.96 and 0.98 was significantly lower than those of patients with SpO2 < 0.96 and SpO2 > 0.98.

CONCLUSIONS: During hospitalization, the level of SpO2 among sepsis patients exhibits a U-shaped relationship with in-hospital all-cause mortality, indicating that heightened and diminished oxygen levels are both associated with increased mortality risk. The optimal SpO2 range is determined to be between 0.96 and 0.98.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Ye Y, Li F, Yang B, et al. [Exploring the optimal range of pulse oxygen saturation in patients with sepsis: a retrospective study based on MIMIC- IV data]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024. PMID: 39238405. doi:10.3760/cma.j.cn121430-20231019-00885

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。